Reemerging Sudan Ebola virus disease in Uganda, 2011

Emerging Infectious Diseases

Volumn 18, Issue 9, 2012, Pages 1480-1483

  MacNeil, Adam ^a   Shoemaker, Trevor ^a   Balinandi, Stephen ^a   Campbell, Shelley ^a   Wamala, Joseph Francis ^b   McMullan, Laura K ^a   Downing, Robert ^a   Lutwama, Julius ^c   Mbidde, Edward ^c   Ströher, Ute ^a   Rollin, Pierre E ^a   Nichol, Stuart T ^a  

^a CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

^b MINISTRY OF HEALTH   (Uganda)

^c UGANDA VIRUS RESEARCH INSTITUTE   (Uganda)

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOGLOBULIN M;

ARTICLE; BAT; CASE REPORT; CHILD; CONJUNCTIVAL HEMORRHAGE; EBOLA HEMORRHAGIC FEVER; EBOLA VIRUS; ENDOTRACHEAL INTUBATION; ENZYME LINKED IMMUNOSORBENT ASSAY; EPIDEMIC; EPISTAXIS; FEMALE; FEVER; GINGIVA BLEEDING; HEMATEMESIS; HEMATURIA; HUMAN; INFECTION CONTROL; JAUNDICE; LABORATORY; NONHUMAN; NUCLEOTIDE SEQUENCE; OXYGEN THERAPY; PATIENT CARE; PHYLOGENY; PUBLIC HEALTH SERVICE; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SCHOOL CHILD; UGANDA; VAGINA BLEEDING;

CHILD; COMMUNICABLE DISEASES, EMERGING; DISEASE OUTBREAKS; EBOLAVIRUS; EPIDEMIOLOGICAL MONITORING; FATAL OUTCOME; FEMALE; HEMORRHAGIC FEVER, EBOLA; HUMANS; UGANDA;

EID: 84865321910     PISSN: 10806040     EISSN: 10806059     Source Type: Journal    
DOI: 10.3201/eid1809.111536     Document Type: Article

References (15)

1. Ksiazek TG, Rollin PE, Williams AJ, Bressler DS, Martin ML, Swanepoel R, et al. Clinical virology of Ebola hemorrhagic fever (EHF): virus, virus antigen, and IgG and IgM antibody findings among EHF patients in Kikwit, Democratic Republic of the Congo, 1995. J Infect Dis. 1999;179(SUPPL. 1):S177-S187.http://dx.doi.org/10.1086/514321
2. Ksiazek TG, West CP, Rollin PE, Jahrling PB, Peters CJ. ELISA for the detection of antibodies to Ebola viruses. J Infect Dis. 1999;179(SUPPL. 1):S192-S198.http://dx.doi.org/10.1086/514313
3. Towner JS, Sealy TK, Ksiazek TG, Nichol ST. high-throughput molecular detection of hemorrhagic fever virus threats with applications for outbreak settings. J Infect Dis. 2007;196(SUPPL. 2):S205-S212.http://dx.doi.org/10.1086/520601
4. Towner JS, Sealy TK, Khristova ML, Albarino CG, Conlan S, Reeder SA, et al. Newly discovered Ebola virus associated with hemorrhagic fever outbreak in Uganda. PLoS Pathog. 2008;4:e1000212.http:// dx.doi.org/10.1371/journal.ppat.1000212
5. Towner JS, Pourrut X, Albarino CG, Nkogue CN, Bird BH, Grard G, et al. Marburg virus infection detected in a common African bat. PLoS ONE. 2007;2:e764.http://dx.doi.org/10.1371/journal. pone.0000764
6. Towner JS, Khristova ML, Sealy TK, Vincent MJ, Erickson BR, Bawiec DA, et al. Marburg virus genomics and association with a large hemorrhagic fever outbreak in Angola. J Virol. 2006;80:6497-6516.http://dx.doi.org/10.1128/JVI.00069-06
7. MacNeil A, Reed Z, Rollin PE. Serologic cross-reactivity of human IgM and IgG antibodies to fi ve species of Ebola virus. PLoS Negl Trop Dis. 2011;5:e1175.
8. Leroy EM, Baize S, Volchkov VE, Fisher-Hoch SP, Georges-Courbot MC, Lansoud-Soukate J, et al. human asymptomatic Ebola infection and strong inflammatory response. Lancet. 2000;355:2210-2215.http:// dx.doi.org/10.1016/S0140-6736(00)02405-3
9. Busico KM, Marshall KL, Ksiazek TG, Roels TH, Fleerackers Y, Feldmann H, et al. Prevalence of IgG antibodies to Ebola virus in individuals during an Ebola outbreak, Democratic Republic of the Congo, 1995. J Infect Dis. 1999;179(SUPPL. 1):S102-S107.http://dx.doi. org/10.1086/514309
10. Gonzalez JP, Nakoune E, Slenczka W, Vidal P, Morvan JM. Ebola and Marburg virus antibody prevalence in selected populations of the Central African Republic. Microbes Infect. 2000;2:39-44.http:// dx.doi.org/10.1016/S1286-4579(00)00287-2
11. Becquart P, Wauquier N, Mahlakoiv T, Nkoghe D, Padilla C, Souris M, et al. high prevalence of both humoral and cellular immunity to Zaire ebolavirus among rural populations in Gabon. PLoS ONE. 2010;5:e9126.http://dx.doi.org/10.1371/journal.pone.0009126
12. Heymann DL, Weisfeld JS, Webb PA, Johnson KM, Cairns T, Berquist H. Ebola hemorrhagic fever: Tandala, Zaire, 1977- 1978. J Infect Dis. 1980;142:372-376.http://dx.doi.org/10.1093/ infdis/142.3.372
13. Centers for Disease Control and Prevention. Outbreak of Ebola hemorrhagic fever Uganda, August 2000-January 2001. MMWR Morb Mortal Wkly Rep. 2001;50:73-77.
14. Wamala JF, Lukwago L, Malimbo M, Nguku P, Yoti Z, Musenero M, et al. Ebola hemorrhagic fever associated with novel virus strain, Uganda, 2007-2008. Emerg Infect Dis. 2010;16:1087-1092.http:// dx.doi.org/10.3201/eid1607.091525
15. MacNeil A, Farnon EC, Wamala J, Okware S, Cannon DL, Reed Z, et al. Proportion of deaths and clinical features in Bundibugyo Ebola virus infection, Uganda. Emerg Infect Dis. 2010;16:1969-1972.